Clindamycin phosphate in 0.9 % sodium chloride (normal saline) is the standard injectable preparation used in hospitals to treat bacterial infections that are susceptible to clindamycin.
Below is a quick‑reference guide that covers what it is, how it’s prepared, and key clinical points.
---
1. What is Clindamycin Phosphate?
| Item | Details |
|------|---------|
| Drug class | Lincosamide antibiotic |
| Mechanism | Binds to the 50S ribosomal subunit → inhibits protein synthesis → bacteriostatic (at low concentrations) / bactericidal (at high concentrations) |
| Spectrum | Anaerobes (e.g., Bacteroides, Clostridium), many gram‑positive cocci and bacilli, some Streptococcus spp. |
| Prodrug | Clindamycin phosphate is converted in the body to active clindamycin. |
| Formulations | 150 mg/mL (1 mL vial) or 300 mg/mL (1 mL vial). |
---
2. Why 0.9 % NaCl?
- Isotonicity – 0.9 % NaCl (normal saline) matches the osmolarity of blood, preventing irritation or tissue damage when the drug is injected into veins or into the pleural cavity, etc.
- Compatibility – Clindamycin phosphate is stable in 0.9 % NaCl at room temperature and can be stored in this solution for a limited period (usually 30 days at 2–8 °C if reconstituted and stored in a sealed vial; some products are pre‑prepared and ready to use).
---
3. Preparation & Storage
1. Reconstitution (if using a lyophilized vial)
- Add the required volume of 0.9 % NaCl (usually 1–2 mL) to the vial.
- Gently swirl until the powder is completely dissolved.
- Resulting concentration: 150 mg/mL or 300 mg/mL depending on vial.
2. Administration
- IV infusion – Dilute with 0.9 % NaCl to the required dose and give over 30 min–2 h (depends on the protocol).
- Intramuscular (IM) – Rarely used in the U.S., but can be given as a single IM injection (dose and volume per protocol).
- Intra‑articular or intra‑ocular – Specialized dosing, usually under specialist supervision.
3. Storage
- Reconstituted solution: 2–8 °C, protected from light, use within 30 days (or per label).
- Unreconstituted vial: 2–25 °C, protected from light, use before expiry.
4. Expiration – Usually 6–12 months for the vial; 30 days for the reconstituted solution (check the specific product label).
---
4. Clinical Use & Dosing (Adult)
| Indication | Typical IV Dose | Administration |
|------------|-----------------|----------------|
| Bacterial skin & soft‑tissue infections | 600 mg q6h | 30 min–2 h infusion |
| Pneumonia (anaerobic) | 600 mg q6h | 30 min–2 h infusion |
| Septicemia | 600 mg q6h | 30 min–2 h infusion |
| Periodontal infection | 600 mg q6h | 30 min–2 h infusion |
| Endodontic/Oral infections | 600 mg q6h | 30 min–2 h infusion |
| Other anaerobic infections | 600 mg q6h | 30 min–2 h infusion |
| Prophylaxis for dental procedures | 600 mg | single dose |
(Doses may be adjusted for renal/hepatic impairment, pregnancy, or pediatric patients; always refer to the product monograph.)
---
5. Safety & Precautions
| Issue | Key Points |
|-------|------------|
| Allergy | Avoid in patients with hypersensitivity to clindamycin or other lincosamides. |
| Toxicity | Rare systemic toxicity; main concerns are GI upset, rash, or Clostridioides difficile colitis. |
| Drug Interactions | Avoid concomitant use with other drugs that suppress the gut flora or increase C. difficile risk (e.g., broad‑spectrum β‑lactams). |
| Renal/Hepatic Impairment | Dose adjustment often needed. |
| Pregnancy & Lactation | Category B; use only if benefit outweighs risk. |
| Monitoring | Watch for signs of C. difficile colitis (watery diarrhea, abdominal pain); consider stool toxin testing if suspected. |
---
6. Common Questions
| Question | Answer |
|----------|--------|
| Can it be used in children? | Yes, dosing is based on weight (usually 8 mg/kg q6h IV). |
| Is it safe for IV push? | Generally recommended to give as an infusion over ≥30 min to reduce vein irritation. |
| What if the patient has a history of C. difficile colitis? | Avoid if possible; consider alternative antibiotics. |
| Can it be combined with other IV antibiotics? | Yes—commonly with β‑lactams or metronidazole, especially for polymicrobial infections. |
---
7. Quick Reference – “Dosage & Infusion” (U.S. Standard)
| Vial (150 mg/mL) | Volume per 600 mg dose | Dilute in 0.9 % NaCl | Total IV volume | Infusion time |
|------------------|------------------------|----------------------|------------------|---------------|
| 4 mL vial (600 mg) | 4 mL | 4 mL (1:1) | 8 mL | 30 min–2 h |
| 2 mL vial (300 mg) | 2 mL | 2 mL (1:1) | 4 mL | 30 min–2 h |
Adjust if using 300 mg/mL vials or higher‑dose preparations.
---
8. Bottom Line
Clindamycin phosphate in 0.9 % NaCl is a widely used, safe, and effective IV antibiotic for infections where anaerobes or susceptible gram‑positives are suspected. Proper reconstitution, infusion rate, and monitoring for C. difficile are essential for optimal therapy.
If you have a specific clinical scenario or dosing question, feel free to share—happy to dive deeper!